{
  "drug_name": "Gemfibrozil",
  "url": "https://wikem.org/wiki/Gemfibrozil",
  "scraped_at": "2026-01-10T07:53:53.698761",
  "sections": {
    "Administration": {
      "text": "Type: Antihyperlipidemic\nDosage Forms: Tablet, 600mg\nRoutes of Administration: oral\nCommon Trade Names: Lopid",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Adult_Dosing": {
      "text": "600mg PO BID 30m before meals",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pediatric_Dosing": {
      "text": "Safety/efficacy not established",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Special_Populations": {
      "text": "Pregnancy Rating\n: C\nLactation risk: Infant risk cannot be ruled out\nRenal dosing: not recommended in severe renal impairment\nHepatic dosing: contraindicated in hepatic dysfunction",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Pregnancy Rating",
          "url": "https://wikem.org/wiki/Drug_pregnancy_categories"
        }
      ]
    },
    "Contraindications": {
      "text": "Allergy to class/drug\nConcomitant dasabuvir, repaglinide, or simvastatin\nHepatic dysfunction, primary biliary cirrhosis, preexisting gallbladder disease\nSevere renal impairment",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Adverse_Reactions": {
      "text": "",
      "subsections": {
        "Serious": {
          "text": "Increased LFTs\nRhabdomyolysis\nAtrial Fibrillation",
          "tables": []
        },
        "Common": {
          "text": "Abdominal pain, indigestion\nAppendicitis\nFatigue, Vertigo\nRash",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Serious": {
      "text": "Increased LFTs\nRhabdomyolysis\nAtrial Fibrillation",
      "subsections": {
        "Common": {
          "text": "Abdominal pain, indigestion\nAppendicitis\nFatigue, Vertigo\nRash",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Common": {
      "text": "Abdominal pain, indigestion\nAppendicitis\nFatigue, Vertigo\nRash",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pharmacology": {
      "text": "Half-life: 1.5h\nMetabolism: Hepatic. Inhibitor of CYP2C8, OATP1B1, and OAT3, substrate of UGT2B7\nExcretion: Mostly renal",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Mechanism_of_Action": {
      "text": "Stimulates peroxisome proliferator activated receptor alpha, which causes a decrease in triglyceride levels and an increase in high-density lipoprotein levels",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "See_Also": {
      "text": "Hypertriglyceridemia",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Hypertriglyceridemia",
          "url": "https://wikem.org/wiki/Hypertriglyceridemia"
        }
      ]
    }
  }
}